Reflections on the AELP National Conference
By Steve Smith, Managing Director
Reflections on the AELP National Conference
By Steve Smith, Managing Director
Cogent Skills is proud to launch its newest report, ‘A greenprint on skills for the low-carbon industries’. This is a strategic roadmap which will help …
Updated Education and Skills Funding Agency (ESFA) Apprenticeship funding rules for the 2023/24 academic year.
Natalie Webster was one of the first cohort of apprentices supported by Cogent Skills in 2012.
The SIP Careers Taskforce is a group of early career professionals from diverse backgrounds who share a passion for science-based careers.
From improved levels of workforce psychological safety to a reduction in process safety related incidents, EPC-UK shares positive outcomes and lessons from adopting the Process Safety Management (PSM) training standards for high hazard industries.
Key players in nuclear have come together to agree a set of four commitments to help deliver the future workforce the sector needs to thrive over the coming decades.
This week, the Institute for Apprenticeships and Technical Education (IfATE) published a new report: ‘A Simpler Skills System’. The report supports IfATE’s strategic objective of ‘Building a more integrated skills system’ and follows last year’s Big Conversation, to which SIP and NSSG members contributed.
Earlier this year, the Institute for Apprenticeships and Technical Education (IfATE) held a public consultation into mandatory qualifications, to which the Science Industry Partnership (SIP) submitted a response. The consultation received more than 300 responses and the outcomes have been published.
What is an Apprenticeship? An apprenticeship is a structured training program that combines on-the-job learning with classroom instruction. It is a valuable pathway for individuals …
LifeArc is an innovative medical research charity which aims to create life-changing advances in the prevention, diagnosis and treatment of disease. Its ground-breaking work currently includes developing new drugs to tackle conditions including cancer, dementia and cystic fibrosis.